RESTRICTED STOCK (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015
Non-cash restricted stock compensation expense	$ 26,000	$ 108,000
Restricted stock	39,290		39,290
Unrecognized compensation expense	$ 213,000		$ 213,000
FDA Approval [Member]
Vesting criteria			14,185 shares of restricted stock vest upon the FDA approval of our CGM system or the sale of the Company
4Years [Member]
Vesting criteria			21,480 shares of restricted stock vest over 4 years, at each of the anniversary dates of the grants
1Year [Member]
Vesting criteria			3,625 shares of restricted stock vest over 1 year, at each of the anniversary dates of the grants